The Fund aims to provide a combination of income and long term capital growth.
Name | % Net Assets |
---|---|
HSBC HLDGS | 8.0% |
ROYAL DUTCH SHELL | 7.5% |
Glaxosmithkline | 7.1% |
BP | 5.0% |
Vodafone Group | 4.4% |
Signet Jewelers Ltd | 4.1% |
Astrazeneca | 3.9% |
Unilever | 3.7% |
Travis Perkins | 3.2% |
British American Tobacco | 2.8% |
Key | % Net Assets |
---|---|
HSBC HLDGS | 8.0% |
ROYAL DUTCH SHELL | 7.5% |
Glaxosmithkline | 7.1% |
BP | 5.0% |
Other | 72.4% |
Date | 01-Mar-2019 |
---|---|
NAV | 1,380.98p |
Currency | GBP |
Change | 18.25p |
% | 1.34% |
YTD change | 1,380.98p |
YTD % | n/a |
Fund Inception | 02/10/1978 |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | £100000000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | 6.00% |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research